|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
IEP |
mRNA:increased expression:iris, ciliary body, popliteal lymph nodes (rat) |
RGD |
PMID:15109911 |
RGD:8549495 |
NCBI chr10:67,503,077...67,504,875
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
no_association |
ISO |
|
RGD |
PMID:24736166 PMID:19357362 |
RGD:8657357, RGD:8657383 |
NCBI chr 8:132,611,883...132,619,106
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte-associated protein 4 |
|
ISO |
|
RGD |
PMID:14528321 PMID:11481266 |
RGD:7204514, RGD:7421509 |
NCBI chr 9:69,812,859...69,819,959
|
|
G |
Cx3cl1 |
C-X3-C motif chemokine ligand 1 |
|
IEP |
mRNA, protein:increased expression:iris, ciliary body, aqueous humor |
RGD |
PMID:16030495 |
RGD:9479740 |
NCBI chr19:10,233,326...10,244,856
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
IEP ISO |
|
RGD |
PMID:16030495 PMID:19689733 |
RGD:9479740, RGD:9491397 |
NCBI chr 8:128,661,294...128,679,048
|
|
G |
Dll4 |
delta like canonical Notch ligand 4 |
disease_progression |
IEP |
|
RGD |
PMID:31209505 |
RGD:155791448 |
NCBI chr 3:126,770,945...126,780,769
|
|
G |
Fas |
Fas cell surface death receptor |
susceptibility |
ISO |
|
RGD |
PMID:11067900 |
RGD:8662852 |
NCBI chr 1:241,212,155...241,245,774
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
|
RGD |
PMID:8100190 |
RGD:8158117 |
NCBI chr 8:27,829,688...27,841,618
|
|
G |
Il10 |
interleukin 10 |
treatment disease_progression |
ISO IEP |
|
RGD |
PMID:18495789 PMID:31209505 PMID:16043105 PMID:18390724 |
RGD:7365044, RGD:155791448, RGD:7365069, RGD:7365052 |
NCBI chr13:45,024,921...45,029,586
|
|
G |
Il17a |
interleukin 17A |
treatment |
IMP IDA IEP |
mRNA:increased expression:lymph node (rat) |
RGD |
PMID:24117055 PMID:23626769 PMID:21686325 |
RGD:9074484, RGD:9173789, RGD:9158567 |
NCBI chr 9:30,640,844...30,644,331
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
human protein in mouse model |
RGD |
PMID:16009838 |
RGD:8549788 |
NCBI chr 3:27,509,836...27,525,738
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
onset |
IEP |
mRNA, protein:increased expression:eye (rat) |
RGD |
PMID:19755419 |
RGD:7207388 |
NCBI chr 8:12,943,453...12,963,966
|
|
G |
Notch1 |
notch receptor 1 |
disease_progression |
IEP |
|
RGD |
PMID:31209505 |
RGD:155791448 |
NCBI chr 3:29,676,040...29,721,613
|
|
G |
Rpe65 |
retinoid isomerohydrolase RPE65 |
|
ISO |
human peptides in a rat model |
RGD |
PMID:16109648 |
RGD:9585652 |
NCBI chr 2:251,425,228...251,457,209
|
|
G |
RT1-CE13 |
RT1 class I, locus CE13 |
treatment |
ISO |
human HLA-B27 peptide in rat model human peptide in rat model; HLA-B27 |
RGD |
PMID:15681796 PMID:9232451 |
RGD:7364916, RGD:7364942 |
NCBI chr20:3,314,491...3,322,815
|
|
G |
Sell |
selectin L |
|
IEP |
protein:increased expression:serum: |
RGD |
PMID:7690324 |
RGD:597015766 |
NCBI chr13:78,950,100...78,969,604
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
ameliorates |
ISO |
|
RGD |
PMID:24993154 |
RGD:151232288 |
NCBI chr10:5,389,574...5,391,265
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
treatment |
ISO |
|
RGD |
PMID:22238646 |
RGD:8694304 |
NCBI chr10:86,311,528...86,363,513
|
|
G |
Tlr4 |
toll-like receptor 4 |
|
ISO |
|
RGD |
PMID:20207969 |
RGD:7794846 |
NCBI chr 5:85,161,247...85,174,882
|
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
treatment |
ISO |
human gene in a mouse model |
RGD |
PMID:25228068 |
RGD:40818264 |
NCBI chr X:30,293,597...30,340,961
|
|
G |
C3 |
complement C3 |
|
ISO |
|
RGD |
PMID:16143328 |
RGD:7401262 |
NCBI chr 9:2,174,412...2,201,339
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO |
mRNA:increased expression:eye: |
RGD |
PMID:12605265 |
RGD:8661671 |
NCBI chr10:67,503,077...67,504,875
|
|
G |
Ccr2 |
C-C motif chemokine receptor 2 |
|
ISO |
mRNA:increased expression:eye: |
RGD |
PMID:12605265 |
RGD:8661671 |
NCBI chr 8:132,611,883...132,619,106
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
ISO |
|
RGD |
PMID:15972638 |
RGD:8547777 |
NCBI chr X:140,164,341...140,176,057
|
|
G |
Cfb |
complement factor B |
treatment |
ISO IMP |
|
RGD |
PMID:20806290 PMID:21216963 |
RGD:7411717, RGD:7411732 |
NCBI chr20:3,970,643...3,976,510
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
IMP |
|
RGD |
PMID:7909311 |
RGD:8547706 |
NCBI chr 8:27,829,688...27,841,618
|
|
G |
Ifng |
interferon gamma |
|
IEP |
mRNA,protein:increased expression:eye: |
RGD |
PMID:1572694 |
RGD:8142388 |
NCBI chr 7:55,789,180...55,793,216
|
|
G |
Il10 |
interleukin 10 |
treatment |
ISO IDA |
|
RGD |
PMID:22629453 PMID:21296818 PMID:15240742 PMID:11359436 |
RGD:7364830, RGD:7364849, RGD:7365075, RGD:7365084 |
NCBI chr13:45,024,921...45,029,586
|
|
G |
Il2 |
interleukin 2 |
disease_progression |
ISO IEP |
mRNA:increased expression:uvea: |
RGD |
PMID:7929845 PMID:7803357 |
RGD:8662951, RGD:8662946 |
NCBI chr 2:121,932,968...121,937,672
|
|
G |
Il4 |
interleukin 4 |
disease_progression |
IEP |
mRNA:increased expression:uvea: |
RGD |
PMID:7803357 |
RGD:8662946 |
NCBI chr10:38,272,003...38,277,549
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
|
RGD |
PMID:18424728 |
RGD:8694299 |
NCBI chr10:86,311,528...86,363,513
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
|
RGD |
PMID:19635911 |
RGD:8661744 |
NCBI chr 4:159,837,119...159,849,817
|
|